Acquiring Company
Codis
Acquired Company
Catalent
ChesterfieldSomersetManufacturingBiotechnologyPharmaceuticalManufacturingBiotechnologyHealth CareDescription
Codis has successfully completed the acquisition of Catalent's facility in Nottingham, UK. This acquisition enhances Codis' capabilities in spray drying and integrates key operations between its locations in Nottingham and Haverhill. The merger aims to accelerate development and manufacturing processes, providing customers with seamless service from development to commercial production.
Related People
M&A Insights
Based on deal dataFrequently asked
Who acquired Catalent?
Catalent was acquired by Codis, based in Chesterfield. The deal was reported on August 3, 2026. Codis is a global CDMO specializing in commercial spray drying, amorphous solid dispersions, particle engineering, and finished dose manufacturing for the pharmaceutical, consumer health, nutraceutical, and OTC sectors. Codis is privately held and operates in Manufacturing.
When did Codis acquire Catalent?
Codis's acquisition of Catalent was reported on August 3, 2026. Codis has successfully completed the acquisition of Catalent's facility in Nottingham, UK. This acquisition enhances Codis' capabilities in spray drying and integrates key operations between its locations in Nottingham and Haverhill. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Catalent do?
Catalent, Inc. (NYSE: CTLT), an S&P 500® company, is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. It is privately held, operating in Manufacturing, and is based in Somerset.